Institutional Ownership
Oyster Point Pharma Inc
CUSIP 69242L106COMOYSTQ1 2026
13D / 13G Filings
21
Schedule 13D/13G on record
Beneficial Filers
7
Distinct reporting persons
Largest Stake
22.1%
Max % of class reported
Institutional Holders
1
13F filers (latest quarter)
Beneficial Owners — Schedule 13D / 13G
21 filings · latest Feb 14, 2023
| # | Filed | Reporting Person | Form | % of Class | Shares | Filing |
|---|---|---|---|---|---|---|
| 1 | Feb 14, 2023 | Paradigm Biocapital Advisors LP | 13G/A | — | — | SEC |
| 2 | Feb 14, 2023 | Rtw Investments, LP | 13G/A | 8.6% | 2.30M | SEC |
| 3 | Feb 14, 2023 | Point72 Asset Management, L.P. | 13G/A | — | — | SEC |
| 4 | Jan 13, 2023 | Versant Venture Capital Vi, L.P. | 13D/A | — | — | SEC |
| 5 | Jan 9, 2023 | New Enterprise Associates 14, L.P. | 13D/A | — | — | SEC |
| 6 | Jan 5, 2023 | Invopps IV Us, L.P. | 13D/A | — | — | SEC |
| 7 | Dec 21, 2022 | Invopps IV Us, L.P. | 13D/A | 3.4% | 917.8K | SEC |
| 8 | Nov 21, 2022 | New Enterprise Associates 14, L.P. | 13D/A | 22.1% | 5.93M | SEC |
| 9 | Jul 18, 2022 | Paradigm Biocapital Advisors LP | 13G | 5.5% | 1.46M | SEC |
| 10 | Feb 14, 2022 | Rtw Investments, LP | 13G/A | 7.9% | 2.06M | SEC |
11 more beneficial-ownership filings on Premium
See the full Schedule 13D/13G history for Oyster Point Pharma Inc.
Unlock full historyTop Institutional Holders (13F)
Largest reported positions · latest quarter
| # | Fund | Shares | Value |
|---|---|---|---|
| 1 | Huntington National Bank | 1 | $11 |